Heather M Scobie - JoVE Visualize

Showing results (41-50 of 62) with videos related to

Pageof 7

Sort By:

Emerging Infectious Diseases|December 11, 2022

Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020John Paul Bigouette, Anna W Callaghan, Morgane Donadel, et al.

MMWR. Morbidity and Mortality Weekly Report|February 2, 2023

Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023Heather M Scobie, Akilah R Ali, Philip Shirk, et al.

Journal of Clinical Microbiology|March 18, 2021

Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population ImmunityMelissa M Coughlin, Zachary Matson, Sun B Sowers, et al.

Vaccines|March 30, 2023

Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?Rania A Tohme, Heather M Scobie, Oyeladun Okunromade, et al.

MMWR. Morbidity and Mortality Weekly Report|February 2, 2023

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.

MMWR. Morbidity and Mortality Weekly Report|November 14, 2024

Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024Brian Lefferts, Sara Bressler, James W Keck, et al.

MMWR. Morbidity and Mortality Weekly Report|April 29, 2021

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021Jessica R MacNeil, John R Su, Karen R Broder, et al.

MMWR. Morbidity and Mortality Weekly Report|May 20, 2021

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021Megan Wallace, Kate R Woodworth, Julia W Gargano, et al.

MMWR. Morbidity and Mortality Weekly Report|July 8, 2021

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021Julia W Gargano, Megan Wallace, Stephen C Hadler, et al.

MMWR. Morbidity and Mortality Weekly Report|October 6, 2022

Increase in Acute Respiratory Illnesses Among Children and Adolescents Associated with Rhinoviruses and Enteroviruses, Including Enterovirus D68 - United States, July-September 2022Kevin C Ma, Amber Winn, Heidi L Moline, et al.

Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:

Pageof 7

Emerging Infectious Diseases|December 11, 2022

Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020John Paul Bigouette, Anna W Callaghan, Morgane Donadel, et al.

MMWR. Morbidity and Mortality Weekly Report|February 2, 2023

Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023Heather M Scobie, Akilah R Ali, Philip Shirk, et al.

Journal of Clinical Microbiology|March 18, 2021

Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population ImmunityMelissa M Coughlin, Zachary Matson, Sun B Sowers, et al.

Vaccines|March 30, 2023

Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?Rania A Tohme, Heather M Scobie, Oyeladun Okunromade, et al.

MMWR. Morbidity and Mortality Weekly Report|February 2, 2023

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.

MMWR. Morbidity and Mortality Weekly Report|November 14, 2024

Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024Brian Lefferts, Sara Bressler, James W Keck, et al.

MMWR. Morbidity and Mortality Weekly Report|April 29, 2021

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021Jessica R MacNeil, John R Su, Karen R Broder, et al.

MMWR. Morbidity and Mortality Weekly Report|May 20, 2021

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021Megan Wallace, Kate R Woodworth, Julia W Gargano, et al.

MMWR. Morbidity and Mortality Weekly Report|July 8, 2021

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021Julia W Gargano, Megan Wallace, Stephen C Hadler, et al.

MMWR. Morbidity and Mortality Weekly Report|October 6, 2022

Increase in Acute Respiratory Illnesses Among Children and Adolescents Associated with Rhinoviruses and Enteroviruses, Including Enterovirus D68 - United States, July-September 2022Kevin C Ma, Amber Winn, Heidi L Moline, et al.

Pageof 7